Can-Fite BioPharma Ltd. CANF
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.30M | -2.30M | -2.48M | -2.48M | -2.44M |
| Total Depreciation and Amortization | 500.00 | 500.00 | 500.00 | 500.00 | 11.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.00K | 34.00K | 50.00K | 50.00K | 161.00K |
| Change in Net Operating Assets | -391.00K | -391.00K | 327.00K | 327.00K | -110.50K |
| Cash from Operations | -2.66M | -2.66M | -2.10M | -2.10M | -2.38M |
| Capital Expenditure | -500.00 | -500.00 | -500.00 | -500.00 | -500.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -500.00K | -500.00K | -1.50M | -1.50M | 1.50M |
| Cash from Investing | -500.50K | -500.50K | -1.50M | -1.50M | 1.50M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.89M | 1.89M | 3.14M | 3.14M | 1.69M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.89M | 1.89M | 3.14M | 3.14M | 1.69M |
| Foreign Exchange rate Adjustments | -- | -- | 500.00 | 500.00 | 4.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.27M | -1.27M | -463.00K | -463.00K | 814.50K |